Earnings Report: Here’s what to expect from BioSig Technologies (NASDAQ:BSGM)


Earnings results for BioSig Technologies (NASDAQ:BSGM)

BioSig Technologies, Inc. is estimated to report earnings on 03/18/2021. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date.

Analyst Opinion on BioSig Technologies (NASDAQ:BSGM)

1 Wall Street analysts have issued ratings and price targets for BioSig Technologies in the last 12 months. Their average twelve-month price target is $9.00, predicting that the stock has a possible upside of 90.27%. The high price target for BSGM is $9.00 and the low price target for BSGM is $9.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of “Buy.”

BioSig Technologies has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $9.00, BioSig Technologies has a forecasted upside of 90.3% from its current price of $4.73. BioSig Technologies has received no research coverage in the past 90 days.

Dividend Strength: BioSig Technologies (NASDAQ:BSGM)

BioSig Technologies does not currently pay a dividend. BioSig Technologies does not have a long track record of dividend growth.

Insiders buying/selling: BioSig Technologies (NASDAQ:BSGM)

In the past three months, BioSig Technologies insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $530,131.00 in company stock. Only 19.49% of the stock of BioSig Technologies is held by insiders. Only 18.33% of the stock of BioSig Technologies is held by institutions.

Earnings and Valuation of BioSig Technologies (NASDAQ:BSGM

BioSig Technologies has a P/B Ratio of 8.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here